Reply to: Time to resize the role of everolimus as treatment of hepatocellular carcinoma recurrence after liver transplant

Publisher: John Wiley & Sons Inc

E-ISSN: 1432-2277|28|4|503-504

ISSN: 0934-0874

Source: TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol.28, Iss.4, 2015-04, pp. : 503-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract